Dow Up1.13% Nasdaq Up1.41%

Pfizer Inc. (PFE)

-NYSE
29.95 Up 0.11(0.37%) 4:00PM EDT
|After Hours : 29.91 Down 0.04 (0.13%) 7:33PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 29, 2014Mar 30, 2014Dec 31, 2013Sep 29, 2013
Total Revenue 12,773,000   11,353,000   13,558,000   12,643,000  
Cost of Revenue2,462,000  2,045,000  2,794,000  2,287,000  
Gross Profit 10,311,000   9,308,000   10,764,000   10,356,000  
Operating Expenses
Research Development1,759,000  1,623,000  1,811,000  1,627,000  
Selling General and Administrative2,897,000  3,663,000  4,152,000  3,395,000  
Non Recurring81,000  58,000  635,000  233,000  
Others1,001,000  1,117,000  1,123,000  1,117,000  
Total Operating Expenses5,738,000  6,461,000  7,721,000  6,372,000  
Operating Income or Loss 4,573,000   2,847,000   3,043,000   3,984,000  
Income from Continuing Operations
Total Other Income/Expenses Net(570,000) -  18,000  (411,000)
Earnings Before Interest And Taxes4,003,000  2,847,000  3,061,000  3,573,000  
Interest Expense -   -   -   -  
Income Before Tax4,003,000  2,847,000  3,061,000  3,573,000  
Income Tax Expense1,082,000  582,000  430,000  985,000  
Minority Interest(9,000)(9,000)(6,000)(9,000)
Net Income From Continuing Ops2,921,000  2,265,000  2,631,000  2,588,000  
Non-recurring Events
Discontinued Operations -  73,000  (57,000)11,000  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 2,912,000   2,329,000   2,568,000   2,590,000  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 2,912,000   2,329,000   2,568,000   2,590,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.